Literature DB >> 27006578

Cellular immune function and liver damage in post-hepatitic cirrhosis.

Z J Feng1, R M Niu1, X L Ren1, X X Yao1.   

Abstract

AIM: To study cellular immune function in patients with post-hepatitic cirrhosis (PHC) and its relationship with different types of liver damage.
METHODS: Fifty-one patients with PHC, including 20 cases of Child-Pugh class A, 18 of class B, 13 of class C and 22 normal subjects as controls were studied. After peripheral blood mononuclear cells were isolated by Ficoll-Hypaque gradient centrifugation, lymphocyte transformation (LT) test, IL-2 activity and NK cell activity were measured by the (3)H-TdR incorporation technique.
RESULTS: Changes of LT stimulation index (SI), IL-2 activity (SI) and NK cell activity (%) in patients with PHC were significantly decreased compared with in the healthy controls (18.1 ± 13.0 vs 34.9 ± 21.7, P < 0.01; 8.1 ± 6.0 vs 13.6 ± 5.8, P < 0.01; 40.3 ± 21.7 vs 61.3 ± 20.5, P < 0.01; respectively). The defects of cellular immune function were closely related to Child-Pugh classification. The values in class C were much lower than those in B and A (P < 0.01) and those in B were lower than those in A (P < 0.05).
CONCLUSION: Defective cellular immune functions in patients with PHC are connected with the degree of liver damage.

Entities:  

Keywords:  Hepatitis; Immunity, cellular; Immunology; Interleukin; Killer cells, natural; Liver cirrhosis; Lymphocyte transformation

Year:  1997        PMID: 27006578      PMCID: PMC4796830          DOI: 10.3748/wjg.v3.i1.22

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Immunology and the liver.

Authors:  M Peters; J Vierling; M E Gershwin; D Milich; F V Chisari; J H Hoofnagle
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

2.  Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage.

Authors:  W L Chuang; H W Liu; W Y Chang; S C Chen; M Y Hsieh; L Y Wang
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

3.  Detection of hepatitis B virus DNA in mononuclear blood cells.

Authors:  P Pontisso; M C Poon; P Tiollais; C Brechot
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

4.  Circulating immune complexes and cell-mediated immunity in patients with hepatitis B virus associated liver diseases.

Authors:  S A Kim; S I Lee; I H Choi; J S Shin; J R Uhm; S J Kim; H J Choi
Journal:  Yonsei Med J       Date:  1990-12       Impact factor: 2.759

5.  T lymphocyte activation in chronic hepatitis B infection: interleukin 2 release and its receptor expression.

Authors:  K N Lai; J C Leung; J S Tam; N W Leung
Journal:  Am J Gastroenterol       Date:  1989-12       Impact factor: 10.864

6.  Depressed immune function in patients with cirrhosis before emergence of hepatocellular carcinoma.

Authors:  T Saibara; T Maeda; M Miyazaki; S Onishi; Y Yamamoto
Journal:  Hepatology       Date:  1993-08       Impact factor: 17.425

Review 7.  Cell-mediated immunity in liver disease.

Authors:  F Paronetto
Journal:  Hum Pathol       Date:  1986-02       Impact factor: 3.466

8.  Kupffer cells modulate natural killer cell activity in vitro by producing prostaglandins.

Authors:  Y Okumura; H Ishibashi; M Shirahama; S Kurokawa; J Kudo; H Okubo; Y Niho
Journal:  Cell Immunol       Date:  1987-06       Impact factor: 4.868

9.  Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants.

Authors:  H F Löhr; W Weber; J Schlaak; B Goergen; K H Meyer zum Buschenfelde; G Gerken
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.